Literature DB >> 658762

Familial and nonfamilial benign recurrent cholestiasis distinguished by plasma disappearance of indocyanine green but not cholylglycine.

G P van Berge-Henegouwen, D R Ferguson, A F Hofmann, A G De Pagter.   

Abstract

To determine whether a defect in uptake of organic anions is present in patients with benign recurrent cholestasis, the plasma disappearance of simultaneously injected indocyanine green and cholyglycine-1-14C was measured in eight patients with asymptomatic benign recurrent cholestasis, four with the familial type, as well as 22 healthy control subjects. Evans blue was also simultaneously injected to permit correction for variation in blood volume and speed of mixing. Uptake of indocyanine green was decreased in all three patients with nonfamilial benign recurrent cholestatsis, but normal or increased in the four patients uith the familial form of the disorder. By contrast, cholyglycine-1-14C uptake was abnormal in one patient with each type of the disorder. Thus, patients with nonfamilial benign recurrent cholestasis have a defect in indocyanine green uptake, and patients with benign recurrent cholestasis are heterogeneous with respect to organic anion uptake.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 658762      PMCID: PMC1412099          DOI: 10.1136/gut.19.5.345

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Validity and sensitivity of an intravenous bile acid tolerance test in patients with liver disease.

Authors:  N F LaRusso; N E Hoffman; A F Hofmann; M G Korman
Journal:  N Engl J Med       Date:  1975-06-05       Impact factor: 91.245

2.  INITIAL DISTRIBUTION AND RATE OF UPTAKE OF SULFOBROMOPHTHALEIN IN THE LIVER.

Authors:  C A GORESKY
Journal:  Am J Physiol       Date:  1964-07

3.  THE SYNDROME OF BENIGN RECURRENT CHOLESTASIS.

Authors:  W H SUMMERSKILL
Journal:  Am J Med       Date:  1965-02       Impact factor: 4.965

4.  Benign recurrent intrahepatic "obstructive" jaundice.

Authors:  W H SUMMERSKILL; J M WALSHE
Journal:  Lancet       Date:  1959-10-31       Impact factor: 79.321

5.  Studies of intestinal digestion and absorption in the human.

Authors:  B BORGSTROM; A DAHLQVIST; G LUNDH; J SJOVALL
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

6.  Tissue distribution of [1(14)C]cholyglycine in rats and hamsters with a bile fistula or bile duct ligation.

Authors:  P Y Ng; A F Hofmann
Journal:  Proc Soc Exp Biol Med       Date:  1977-01

7.  Marked delay in indocyanine green plasma clearance with a near-normal bromosulphophthalein retention test: a constitutional abnormality?

Authors:  K Okuda; H Ohkubo; H Musha; K Kotoda; H Abe; K Tanikawa
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

8.  Uptake of bile acids by perfused rat liver.

Authors:  J Reichen; G Paumgartner
Journal:  Am J Physiol       Date:  1976-09

9.  Hepatic organic anion uptake in the rat.

Authors:  B F Scharschmidt; J G Waggoner; P D Berk
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Evaluation of fluorimetrically estimated serum bile acid in liver disease.

Authors:  T Osuga; K Mitamura; F Mashige; D Imai
Journal:  Clin Chim Acta       Date:  1977-02-15       Impact factor: 3.786

View more
  2 in total

1.  Benign recurrent intrahepatic cholestasis: studies of bilirubin kinetics, bile acids, and cholangiography.

Authors:  J A Summerfield; J Scott; M Berman; C Ghent; J R Bloomer; P D Berk; S Sherlock
Journal:  Gut       Date:  1980-02       Impact factor: 23.059

2.  Biliary lipid metabolism in children with chronic intrahepatic cholestasis.

Authors:  M Becker; K von Bergmann; H W Rotthauwe; O Leiss
Journal:  Eur J Pediatr       Date:  1984-11       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.